BRIEF published on 03/27/2026 at 10:45, 3 hours 46 minutes ago Shreehas Tambe Appointed as CEO & Managing Director of Biocon Limited Biopharmaceuticals Global Market Strategy Biocon Leadership Shreehas Tambe Corporate Integration
PRESS RELEASE published on 03/27/2026 at 10:40, 3 hours 51 minutes ago Shreehas Tambe Appointed CEO & Managing Director of Biocon Limited, Effective April 1, 2026 Shreehas Tambe appointed as CEO & Managing Director of Biocon Limited, leading biosimilars and generics to compete globally. Smooth leadership transition for sustainable growth Biosimilars CEO Generics Shreehas Tambe Biocon Limited
Published on 03/27/2026 at 12:30, 2 hours 2 minutes ago Pasinex Closes First Tranche of Over-Subscribed Non-Brokered Private Placement
Published on 03/27/2026 at 12:00, 2 hours 32 minutes ago Temas Appoints Scientific Advisory Board to Accelerate RCL Commercialisation and Global Development
Published on 03/27/2026 at 11:00, 3 hours 32 minutes ago RE Royalties Announces Strategic Review to Evaluate Path for Long-Term Value Creation
Published on 03/27/2026 at 09:30, 5 hours 2 minutes ago Amap Street Stars Launches Macao Authentic Delicacies Ranking to Drive Cultural-Tourism Innovation in the Greater Bay Area
Published on 03/27/2026 at 14:28, 4 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 03/27/2026 at 14:26, 5 minutes ago Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc
Published on 03/27/2026 at 14:25, 6 minutes ago Form 8.3 - The Vanguard Group, Inc.: International Personal Finance plc
Published on 03/26/2026 at 18:17, 20 hours 15 minutes ago Eiffage strengthens its position in Getlink capital
Published on 03/26/2026 at 17:45, 20 hours 47 minutes ago Cegedim: profitability continues to improve
Published on 03/26/2026 at 07:30, 1 day 7 hours ago BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
